Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Cytokinetics Inc (CYTK) – Cytokinetics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Cytokinetics (CYTK) trades at $72.29, up 2.23% with bullish technical signals and strong analyst support. The stock shows positive momentum with RSI indicating potential oversold conditions at 29.97. Despite significant losses (-$784.96M net income in 2025), revenue growth is accelerating from $88M to $106M projected for 2026, driven by the successful U.S. and European launch of MYQORZO. The company recently raised $805M through a public offering, strengthening its financial position for continued commercialization efforts.
CYTK presents a high-risk, high-reward opportunity with 94% analyst buy ratings and a $106.80 consensus target representing 48% upside. The primary investment thesis revolves around MYQORZO's commercial success, but substantial losses, negative margins (-784.02%), and high valuation (P/S 81.94) require careful risk assessment. Near-term catalysts include European expansion execution and upcoming Q2 earnings, while long-term viability depends on achieving profitability and market penetration against established competitors.
Read full analysis

Key Stats

  • Market Cap
    $9.70B
  • Sector
    Technology
  • 3M Drawdown
    -10.7%
  • Enterprise Value
    $10.18B
  • Dividend Yield
    -
  • Typical Hold Time
    10 days
$71.48
52W Low: $32.3
06 Jun 2025
52W High: $78.77
20 May 2026

Cytokinetics Inc (CYTK) is currently valued at a market capitalization of $9.70B, with an enterprise value of $10.18B. Over the past 52 weeks, Cytokinetics Inc has traded between a low of $32.3 and a high of $78.77, highlighting its annual price range. Over the past three months, Cytokinetics Inc has recorded a drawdown of -10.7%, reflecting recent price volatility. On average, investors hold Cytokinetics Inc for approximately 10 days, indicating typical investor behavior on the platform.

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $9.70B
  • Sector
    Technology
  • 3M Drawdown
    -10.7%
  • Enterprise Value
    $10.18B
  • Dividend Yield
    -
  • Typical Hold Time
    10 days
$71.48
52W Low: $32.3
06 Jun 2025
52W High: $78.77
20 May 2026

Cytokinetics Inc (CYTK) is currently valued at a market capitalization of $9.70B, with an enterprise value of $10.18B. Over the past 52 weeks, Cytokinetics Inc has traded between a low of $32.3 and a high of $78.77, highlighting its annual price range. Over the past three months, Cytokinetics Inc has recorded a drawdown of -10.7%, reflecting recent price volatility. On average, investors hold Cytokinetics Inc for approximately 10 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!